Therapy With an Oxytocin Adjunct for Major Depression
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This study evaluates the addition of intranasal oxytocin to the treatment of Major Depression
using interpersonal psychotherapy. Half of the participants will receive a placebo adjunct to
interpersonal psychotherapy, and the other half will receive oxytocin.
Phase:
Phase 2
Details
Lead Sponsor:
Concordia University Concordia University, Montreal